call beat expand access
improv volume price uncertainti remain
earlier today publish first look result link
addit takeaway confer call overal result reflect
combin expect volume benefit unh/aet contract chang volume
growth carri acquisit stabil hospit refer busi
improv revenu per requisit given mix better collect payment partial
off-set continu medicar price pressur loss hand
region capit contract due competitor price aggress
headwind volum management continu frame price headwind
spread rel evenli beyond multipl factor discuss
number factor could also skew revenu per requisit either
concess magnitud factor drive rev/req
key variabl model top organ volum headwind
includ extra sell day solid yoy growth due softer comp
sustain growth take time play
dgx unchang full-year guid includ signific volum gain unh
prefer lab network pln given time effort need educ physician
still await pln full detail howev take time share gain
competit dynam industri consolid theme play contribut
sustain uptick core organ growth addit management indic anthem
strategi lower hospit lab test impact hospit provid
adjust estim sale rais po
model sale adj ep estimate
primarili beat higher sale margin assumpt rais po
still base ev/ebitda estimate although believ
nation lab eventu benefit on-going lab industri turmoil remain
cautiou given uncertainti reiter under-perform rate
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
largest provid clinic diagnost
test relat servic deliv
nation network full-servic clinic
laboratori patient servic center
clinic lab oper highli competit
price-deflationari environ although
long-term see upsid potenti
elev lab consolid catalyz medicar
opportun monet lab data recent
multipl guidanc cut suggest visibl
limit see potenti
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
price object base ev/ebitda multipl est
line compani histor median year forward multipl view
multipl appropri given fewer concern diagnost landscap
upsid risk faster expect materi hospit lab consolid
trend margin expans due higher specialti test mix faster volum growth
consum genom trend
downsid risk greater expect price headwind lower expect test
volum growth competit execut risk integr risk data privaci risk
derik de bruin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us life scienc diagnost tool anim health coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
